SCHEMBL5904084

SCHEMBL5904084

c1cc2c(cc1OCCCN1CCCCC1)CCC(CN1CCCC1)C2

nearest known ligand 0.77

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 19/20 0.77
HRH1 P35367 4/20 0.77
BACE1 P56817 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5904114 0.99 HRH3 (0.75) HRH3HRH1BACE1
Hydrochloric Acid SCHEMBL5904246 0.98 HRH3 (0.73) HRH3HRH1BACE1
SCHEMBL5904192 0.95 HRH3 (0.69) HRH3HRH1BACE1
SCHEMBL5904187 0.94 HRH3 (0.77) HRH3HRH1
Hydrochloric Acid SCHEMBL5904064 0.93 HRH3 (0.74) HRH3HRH1BACE1
SCHEMBL5904130 0.93 HRH3 (0.74) HRH3HRH1BACE1
SCHEMBL5904125 0.92 HRH3 (0.66) HRH3HRH1
Hydrochloric Acid SCHEMBL5904181 0.92 HRH3 (0.66) HRH3HRH1
SCHEMBL5904091 0.92 HRH3 (0.67) HRH3HRH1BACE1
Hydrochloric Acid SCHEMBL5904180 0.91 HRH3 (0.65) HRH3HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006046131-A1 TETRALIN HISTAMINE-3 RECEPTOR ANTAGONISTS PFIZER PRODUCTS INC. (US) 2006-05-04 WO claimed
US-20060094719-A1 Tetralin histamine-3 receptor antagonists PFIZER INC 2006-05-04 US claimed
WO-2006046131-A1 TETRALIN HISTAMINE-3 RECEPTOR ANTAGONISTS PFIZER PRODUCTS INC. (US) 2006-05-04 WO disclosed
US-20060094719-A1 Tetralin histamine-3 receptor antagonists PFIZER INC 2006-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094719-A1 Tetralin histamine-3 receptor antagonists HRH3, HRH4, HRH1 HRH3 1/4885HRH1 3/4885BACE1 455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.